首页> 外国专利> CHEMICAL SYNTHESIS OF (3R,5R)-DIHYDROXY-7-2-(4-FLUOROPHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-1-PYRROLYL-HEPTANOC ACID, CALCIUM SALT, TRIHYDRATE, PHARMACEUTICAL FORMULATION APPLICATION AND PRODUCTION PROCEDURE.

CHEMICAL SYNTHESIS OF (3R,5R)-DIHYDROXY-7-2-(4-FLUOROPHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-1-PYRROLYL-HEPTANOC ACID, CALCIUM SALT, TRIHYDRATE, PHARMACEUTICAL FORMULATION APPLICATION AND PRODUCTION PROCEDURE.

机译:化学合成(3R,5R)-二羟基-7- [2-(4-氟苯基)-5-异丙烯基-3-苯基-4-苯基氨基甲酰基-1-吡咯基]-庚酸,钙盐,三水合物,药物配方的应用和生产程序。

摘要

Atorvastatin is a synthetic hydroxy-methyl-glutaryl inhibitor of coenzyme A reductase (HMG-CoA), which has been proven effective in reducing cholesterol and triglycerides. The inhibitor of coenzyme A reductase has also been proven effective in lowering cholesterol and triglycerides. It is administered as calcium salt in amounts between 10 to 80 mg per day to lower the high lipid levels in patients at early stages of hyperlipidaemia or combined hyperlipidaemia. It is administered as calcium salt of the active hydroxy-carboxylic acid and is used in quantities 10 to 80 mg per day to lower the high lipid limits in patients suffering from hyperlipidaemia at early stage or for inherited hyperlipidaemia (A.P. Lea, D. Mc Tavish, Drugs 53 (1997) 828-847).
机译:阿托伐他汀是辅酶A还原酶(HMG-CoA)的合成羟甲基-甲基-戊二酰抑制剂,已被证明可有效降低胆固醇和甘油三酸酯。辅酶A还原酶的抑制剂也已被证明可有效降低胆固醇和甘油三酸酯。它以钙盐的形式每天10至80 mg的剂量给药,以降低高脂血症或合并高脂血症早期患者的高血脂水平。它以活性羟基羧酸的钙盐形式给药,每天用量为10至80 mg,以降低早期患有高脂血症或遗传性高脂血症的患者的高脂水平(AP Lea,D。Mc Tavish ,Drugs 53(1997)828-847)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号